At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
GELS Gelteq
Market Closed 12-12 16:00:00 EST
1.01
-0.08
-7.34%
盘后1.01
+0.000.00%
19:55 EST
High1.09Low1.00Vol40.67K
Open1.06D1 Closing1.09Amplitude8.25%
Mkt Cap10.82MTradable Cap4.82MTotal Shares10.71M
T/O42.49KT/O Rate0.85%Tradable Shares4.77M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Gelteq Signs Three-Year Sales Agreement With Shenzhen Mana Health Management for Nutritional Products in China
Reuters  ·  12-09
Gelteq Signs Three-Year Sales Agreement With Shenzhen Mana Health Management for Nutritional Products in China
Gelteq Signs Three Year Sales Agreement With Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion Into China
THOMSON REUTERS  ·  12-09
Gelteq Signs Three Year Sales Agreement With Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion Into China
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform
GlobeNewswire  ·  12-05
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform
Gelteq to Present at Investor Summit Virtual on December 9, 2025
GlobeNewswire  ·  12-02
Gelteq to Present at Investor Summit Virtual on December 9, 2025
Gelteq announces ‘positive’ preclinical results for its gel formulation
TIPRANKS  ·  11-24
Gelteq announces ‘positive’ preclinical results for its gel formulation
Gelteq Ltd - Formulation Shows 38-45% Increase in Systemic Exposure
THOMSON REUTERS  ·  11-24
Gelteq Ltd - Formulation Shows 38-45% Increase in Systemic Exposure
Gelteq Ltd: Anticipates Using These Results to Further Pursue FDA Approval Pathway for Antihistamine Product
THOMSON REUTERS  ·  11-24
Gelteq Ltd: Anticipates Using These Results to Further Pursue FDA Approval Pathway for Antihistamine Product
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
GlobeNewswire  ·  11-24
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
Gelteq Ltd. Delays Financial Report Filing
Reuters  ·  11-04
Gelteq Ltd. Delays Financial Report Filing
Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform
GlobeNewswire  ·  10-23
Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform
Gelteq enters Product Development, Profit Share Agreement with Melbourne Health
TIPRANKS  ·  10-09
Gelteq enters Product Development, Profit Share Agreement with Melbourne Health
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound
GlobeNewswire  ·  10-09
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound
Gelteq powers U.S. product launches of Healthy Extracts
TIPRANKS  ·  09-12
Gelteq powers U.S. product launches of Healthy Extracts
Top Midday Gainers
MT Newswires Live  ·  09-06
Top Midday Gainers
BRIEF-Gelteq Begins Preclinical Trial for Novel Gel-Based Antihistamine Targeting Allergy Market
Reuters  ·  09-05
BRIEF-Gelteq Begins Preclinical Trial for Novel Gel-Based Antihistamine Targeting Allergy Market
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market
THOMSON REUTERS  ·  09-05
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market
Gelteq Ltd - Plans Human Trials for FDA Approval
THOMSON REUTERS  ·  09-05
Gelteq Ltd - Plans Human Trials for FDA Approval
Healthy Extracts Inc. Reports Record Q2 2025 Sales, Achieves Nearly $100K Adjusted EBITDA with 34% Net Revenue Growth Maintained for Year
Reuters  ·  07-22
Healthy Extracts Inc. Reports Record Q2 2025 Sales, Achieves Nearly $100K Adjusted EBITDA with 34% Net Revenue Growth Maintained for Year
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities
GlobeNewswire  ·  07-17
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities
IDT Australia Signs Manufacturing Facility Deal for Gelteq's Products
MT Newswires Live  ·  07-17
IDT Australia Signs Manufacturing Facility Deal for Gelteq's Products

Introduction

Company Name.
Gelteq
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--